2 of 3 listed pharmas are having under 10% operating profit ratio

While increases in introduced products and SG&A expenses have been criticized as the main causes to weaken the pharmaceutical companies’ profitability, it was observed there were only 21 pharmaceutical companies exceeded 10% in operating profit ratio among the 60 listed pharmaceutical companies.

According to the Yakup Shinmoon’s(www.yakup.com) analysis result of the KOSPI and KOSDAQ listed pha...